Appointment of Independet Director

Remedium Lifecare Ltd (BSE Scrip 539561, formerly Roxy Exports Ltd) held a board meeting on 30 May 2025 where it approved audited financial results for Q4 and FY ended 31 March 2025 on both standalone and consolidated basis, with the statutory auditor issuing an unmodified opinion. Consolidated FY25 total income stood at Rs. 41,605.37 lakh with a net profit of Rs. 212.94 lakh, while Q4 FY25 alone posted a loss of Rs. 204.60 lakh on revenue of Rs. 26,498.20 lakh. The board appointed two new Independent Directors – Mr. Bikram Kumar Mund (DIN 06919513) and Mr. Vijay Pal Singh Gulya (DIN 01433784) – each for a first term of five years, subject to shareholder approval. It also appointed Mr. Kapil Goplani as Company Secretary cum Compliance Officer w.e.f. 1 June 2025, and Ms. Riddhi Shah as Secretarial Auditor for five years from FY 2025-26 to FY 2029-30. The company has nil outstanding qualified borrowings, and networth stood at Rs. 4,295.78 lakh as on 31 March 2025, slightly lower than Rs. 4,329.51 lakh a year earlier.